Grant: Discovery Grants Program - Individual
Université de Montréal
$40,000.00
Microscale analytical methods and sample processing tools for biomolecule characterization
EF 2009-10
Résumé
Our research group develops strategies and instrumentation for identifying and quantifying two classes of biological molecules: proteins and sugars. We are studying ways to quantify trace levels of proteins in biological fluids through a technique called peptide mapping, which can identify whether a protein has been changed as a result of disease. When this technique is used in conjunction with mass spectrometry (MS), which measures the masses of each peptide, and with fluorescence detection (LIF), which determines how much peptide is present, the parent protein can be identified and quantified by its daughter peptide masses. We use enzymes that are insoluble as a means of fragmenting the large protein into its constituent daughter peptides. Mapping of these peptides can be done by microscale separation techniques called capillary electrophoresis and liquid chromatography, which are coupled to MS and to LIF. Our proposal describes how we will immobilize a particular enzyme (e.g., trypsin, chymotrypsin, etc.) into a capillary-sized column (microreactor) and then use it to cut a purified protein into peptide fragments as the protein solution is flowed through the immobilized-enzyme micoreactor. Various strategies will be used to develop and optimize: a) the procedures for isolating proteins from a biological sample, b) the microreactor for cutting the proteins into peptide fragments, c) separating, identifying and quantifying (i.e., mapping) the peptide fragments as a means to determine the amounts of each protein in the biological sample. When proteins from healthy and diseased individuals are different, they may represent important biomarkers for that disease. The significance of discovering a biomarker is its potential for developing new therapies. If such proteins could be detected early, when their concentration is still very low, treatment would be more effective.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
155515-2008
Name nom
Waldron, Karen
Department département
Chimie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2008
Award amount
40000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
26
Committee name en
Anal. & Phys. Chemistry
Committee name fr
Chimie analytique et physique
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3503
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Separation methods
Research subject fr
Méthodes de séparation
Partie
2
Nb partie
2
Application title
Microscale analytical methods and sample processing tools for biomolecule characterization
Keyword
NA
Application summary
Our research group develops strategies and instrumentation for identifying and quantifying two classes of biological molecules: proteins and sugars. We are studying ways to quantify trace levels of proteins in biological fluids through a technique called peptide mapping, which can identify whether a protein has been changed as a result of disease. When this technique is used in conjunction with mass spectrometry (MS), which measures the masses of each peptide, and with fluorescence detection (LIF), which determines how much peptide is present, the parent protein can be identified and quantified by its daughter peptide masses. We use enzymes that are insoluble as a means of fragmenting the large protein into its constituent daughter peptides. Mapping of these peptides can be done by microscale separation techniques called capillary electrophoresis and liquid chromatography, which are coupled to MS and to LIF. Our proposal describes how we will immobilize a particular enzyme (e.g., trypsin, chymotrypsin, etc.) into a capillary-sized column (microreactor) and then use it to cut a purified protein into peptide fragments as the protein solution is flowed through the immobilized-enzyme micoreactor. Various strategies will be used to develop and optimize: a) the procedures for isolating proteins from a biological sample, b) the microreactor for cutting the proteins into peptide fragments, c) separating, identifying and quantifying (i.e., mapping) the peptide fragments as a means to determine the amounts of each protein in the biological sample. When proteins from healthy and diseased individuals are different, they may represent important biomarkers for that disease. The significance of discovering a biomarker is its potential for developing new therapies. If such proteins could be detected early, when their concentration is still very low, treatment would be more effective.